Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02395172
Title Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

lung non-small cell carcinoma

Therapies

Avelumab

Docetaxel

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | BEL

Additional content available in CKB BOOST